Regarding the extrinsic apoptotic pathway, the tumor necrosis factor-related apoptosis inducing ligand (TRAIL) is a potent cell death inducer in GBMs by DR4/5 activation, and the treatment with TRAIL plus TMZ has shown a synergistic survival benefit against GBM in vivo [178]. This evidence concerns the gene TNFSF10 and glioblastoma.